DKSH has entered into a strategic partnership with Osteopore to provide comprehensive commercial and logistics services for its advanced regenerative dental product portfolio in Malaysia. This collaboration reinforces DKSH’s commitment to expanding access to innovative medical technologies while strengthening Osteopore’s presence in the Malaysian dental market.
Petaling Jaya, Malaysia, February 19, 2026 – DKSH Business Unit Healthcare, a leading partner for companies seeking to grow their healthcare business in Asia and beyond, has entered into a strategic partnership with Osteopore Limited, a global leader in 3D-printed biomimetic and bioresorbable implants, to enhance the distribution, commercial coverage, and operational excellence of its dental solutions in Malaysia.
Through this collaboration, DKSH will support the nationwide distribution of Osteopore’s advanced dental products, expanding access to innovative regenerative technologies for dental professionals across the country. Under the agreement, DKSH will provide full market expansion services, including sales, marketing, distribution and logistics, as well as customer engagement and channel management, to drive Osteopore’s growth across key healthcare and dental channels.
This partnership builds on DKSH’s strong track record in healthcare distribution and its role as a trusted partner to leading medical technology and life sciences companies. By combining Osteopore’s product innovation with DKSH’s extensive commercial capabilities, both organizations aim to accelerate market adoption and further enhance standards of care in dental and regenerative medicine.
Dr Yujing Lim, Chief Executive Officer at Osteopore Limited commented: “We are glad to have secured a partnership with DKSH Malaysia shortly after the clinical study about comparing Osteopore’s polycaprolactone membrane with a collagen membrane. With local clinical data being generated by the leading research university hospital, University Malaysia (UM) in Malaysia, we can expect to leverage the clinical outcomes to support in-market adoption. As we continue to realign and strengthen our sales and distribution channels in a progressive and organized manner, we look forward to a strong partnership with DKSH Malaysia to introduce a technology that is experiencing growing traction in the market.”
Sandeep Tewari, Vice President, Healthcare and Head, Country Leadership, Malaysia, DKSH added: “Osteopore’s technology has the potential to be first-in-class in Malaysia, and we are excited to support the launch of this innovative solution and to make it accessible to healthcare professionals and patients across the market. Clinicians within our network have expressed strong interest in Osteopore’s products, especially when bone regrowth and augmentation are required. This partnership reinforces DKSH’s commitment to providing healthcare for all by delivering advanced medical innovations that elevate the standard of care across Malaysia.”
Together, DKSH and Osteopore and DKSH Malaysia are committed to driving strong and sustainable growth for the brand, supported by increasing clinical adoption and expanding market reach nationwide, providing healthcare for all.
About Osteopore Limited
OsteoporeLtd. is a global medical technology company founded in Singapore and listed in Australia that commercialises products designed to enable natural bone healing across multiple therapeutic areas. Osteopore’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. Osteopore’s patent-protected scaffolds are manufac-tured using a proprietary manufacturing technique with a polymer that naturally dissolves over time to only allow natural and healthy bone tissue, significantly reducing the post-surgery complications com-monly associated with permanent bone implants. Their 3D printing technology is unique to Osteopore. www.osteopore.com
About DKSH
For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people’s lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter prod-ucts and medical devices. With around 7,580 specialists, the Business Unit generated net sales of CHF 5.8 billion in 2025. www.dksh.com/hec